Mental health of patients with Parkinson’s Disease in an outpatient service in Belém
DOI:
https://doi.org/10.5327/prmj.960Keywords:
anxiety, depression, Parkinson Disease, socioeconomic factors, Mental HealthAbstract
Purpose: To evaluate the prevalence of anxiety and depression and the factors that influence this indicator in patients diagnosed with Parkinson's disease followed up at a state health facility. Methods: A cross-sectional, observational, and mixed-methods study was conducted with patients diagnosed with PD, with preserved communicative and cognitive abilities, who attended the neurology outpatient clinic of the Metropolitan Polyclinic of Belém do Pará between August and October 2025. The socioeconomic profile of the participants was determined using a questionnaire developed by the researchers, while the prevalence of anxiety and depression was assessed using the Hospital Anxiety and Depression Scale. The collected data underwent descriptive and inferential statistical analysis, adopting a p-value of 0.05 as the threshold for statistical significance. Results: The final study sample consisted of 19 patients. Among them, 1 presented symptoms suggestive of anxiety only, 2 presented symptoms suggestive of depression only, and 8 exhibited results suggestive of both anxiety and depression. Although not statistically significant in the tests applied, it was found that there were more patients with symptoms suggestive of depression and anxiety in the 65-year age group; in males; in the Black population; with other health dysfunctions; and in those with a family income of up to 1 minimum wage. Conclusion: Parkinson’s disease influences patients’ quality of life, especially in mental health parameters. Therefore, the creation of care protocols that integrate the assessment of anxiety and depression in the management of the disease is urgently needed, ensuring a better quality of life.
Downloads
References
1. Silva ABRL, Gonçalves de Oliveira RW, Diógenes GP, Aguiar MFC, Sallem CC, Lima MPP, et al. Premotor, nonmotor and motor symptoms of Parkinson’s Disease: A new clinical state of the art. Ageing Res Rev. 2023;84:101834. https://doi.org/10.1016/j.arr.2022.101834
2. Ye H, Robak LA, Yu M, Cykowski M, Shulman JM. Genetics and Pathogenesis of Parkinson’s Syndrome. Annu Rev Pathol. 2023;18:95‑121. https://doi.org/10.1146/annurev-pathmechdis-031521-034145
3. Costa HN, Esteves AR, Empadinhas N, Cardoso SM. Parkinson’s Disease: A Multisystem Disorder. Neurosci Bull. 2023;39(1):113‑24. https://doi.org/10.1007/s12264-022-00934-6
4. Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR. Health-related quality of life in patients with Parkinson’s disease: A systematic review of disease-specific instruments. Mov Disord. 2011;26(2):237-48.
5. Brasil. Ministério da Saúde. Depressão: definição. Linhas de Cuidado [Internet]. 2025 [acessado em 14 set. 2025]. Disponível em: https://linhasdecuidado.saude.gov.br/portal/depressao/definicao/
6. Brasil. Ministério da Saúde. Depressão: informações gerais. Gov.br – Saúde [Internet]. 2025 [acessado em 14 set. 2025]. Disponível em: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/d/depressao.
7. Schrag A, Taddei RN. Depression and anxiety in parkinson’s disease. Int Rev Neurobiol. 2017;133:623-55. https://doi.org/10.1016/bs.irn.2017.05.024
8. Cong S, Xiang C, Zhang S, Zhang T, Wang H, Cong S. Prevalence and clinical aspects of depression in Parkinson’s disease: a systematic review and meta‑analysis of 129 studies. Neurosci Biobehav Rev. 2022;141:104749. https://doi.org/10.1016/j.neubiorev.2022.104749
9. Upneja A, Paul BS, Jain D, Choudhary R, Paul G. Anxiety in Parkinson’s Disease: Correlation with Depression and Quality of Life. J Neurosci Rural Pract. 2021;12(2):323-8. https://doi.org/10.1055/s-0041-1722840
10. Elefante C, Brancati GE, Bacciardi S, Mazzucchi S, Prete ED, Palermo G et al. Prevalence and Clinical Correlates of Comorbid Anxiety and Panic Disorders in Patients with Parkinson’s Disease. J Clin Med. 2021;10(11):2302. https://doi.org/10.3390/jcm10112302
11. Carvalho MO, Rabelo D, Santos MC, Dunningham W. Associação dos sintomas depressivos e ansiosos em pacientes neurológicos assistidos em um ambulatório de Salvador-Bahia. RBNP. 2019;23(1):57-69.
12. Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson’s disease: A systematic review and meta-analysis. Mov Disord. 2014;29(13):1583-90. https://doi.org/10.1002/mds.25945
13. Botega NJ, Bio MR, Zomignani MA, Garcia Jr C, Pereira WAB. Transtornos do humor em enfermaria de clínica médica e validação de escala de medida (HAD) de ansiedade e depressão. Rev Saúde Pública. 1995;29(5):355-63. https://doi.org/10.1590/S0034-89101995000500004
14. Botega NJ, Pondé MP, Medeiros P, Lima MG, Guerreiro CAM. Validação da escala hospitalar de ansiedade e depressão (HAD) em pacientes epilépticos ambulatoriais. J Bras Psiquiatr. 1998;47(6):285-9.
15. Li L, Wang Z, You Z, Huang J. Prevalence and influencing factors of depression in patients with Parkinson’s Disease. Alpha Psychiatry. 2023;24(6):234-8. https://doi.org/10.5152/alphapsychiatry.2023.231253
16. Aarsland D, Kramberger MG. Neuropsychiatric symptoms in Parkinson’s Disease. J Parkinson Dis. 2015;5(3):659-67. https://doi.org/10.3233/JPD-150604
17. Goldman JG. Non-motor symptoms and treatments in Parkinson’s disease. Neurol Clin. 2025;43(2):291-317. https://doi.org/10.1016/j.ncl.2024.12.008
18. Gardoni A, Sarasso E, Basaia S, Corbetta D, Zenere L, Grassi A, et al. Handwriting, touchscreen dexterity and bradykinesia measures in Parkinson’s disease: a feature selection study. J Neurol. 2025;272(6):389. https://doi.org/10.1007/s00415-025-13121-0
19. Tanner CM, Ostrem JL. Parkinson’s Disease. N Engl J Med. 2024;391(5):442-52. https://doi.org/10.1056/nejmra2401857
20. Pereira GM, Teixeira-Dos-Santos D, Soares NM, Marconi GA, Friedrich DC, Awad PS, et al. A systematic review and meta-analysis of the prevalence of Parkinson’s disease in lower to upper-middle-income countries. NPJ Parkinsons Dis. 2024;10(1):181. https://doi.org/10.1038/s41531-024-00779-y
21. Luo Y, Qiao L, Li M, Wen X, Zhang W, Li X. Global, regional, national epidemiology and trends of Parkinson’s disease from 1990 to 2021: findings from the Global Burden of Disease Study 2021. Front Aging Neurosci. 2025;16:1498756. https://doi.org/10.3389/fnagi.2024.1498756
22. Jacob EL, Gatto NM, Thompson A, Bordelon Y, Ritz B. Occurrence of depression and anxiety prior to Parkinson’s disease. Parkinsonism Relat Disord. 2010;16(9):576-81. https://doi.org/10.1016/j.parkreldis.2010.06.014
23. Cattaneo C, Pagonabarraga J. Sex Differences in Parkinson’s Disease: A Narrative Review. Neurol Ther. 2025;14:57-70. https://doi.org/10.1007/s40120-024-00687-6
24. Maas BR, Göttgens I, Klasen HPST, Kapelle WM, Radder DLM, Bloem BR, et al. Age and gender differences in non-motor symptoms in people with Parkinson’s disease. Front Neurol. 2024;15:1339716. https://doi.org/10.3389/fneur.2024.1339716
25. Schlickmann TH, Tessari MS, Borelli WV, Marconi GA, Pereira GM, Zimmer E, et al. Prevalence, distribution and future projections of Parkinson disease in Brazil: insights from the ELSI-Brazil cohort study. Lancet Reg Health Am. 2025;44:101046.
26. Instituto Brasileiro de Geografia e Estatística (IBGE). Censo 2022 [Internet]. 2025 [acessado em 29 nov. 2025]. Disponível em: https://cidades.ibge.gov.br/brasil/pa/pesquisa/10102/122229
27. Siddiqi S, Ortiz Z, Simard S, Li J, Lawrence K, Redmond M, et al. Race and ethnicity matter! Moving Parkinson’s risk research towards diversity and inclusiveness. NPJ Parkinson’s Dis. 2025;11(1): 45. https://doi.org/10.1038/s41531-025-00891-7
28. Quadra MR, Shäfer AA, Meller FO. Inequalities in the use of health services in a municipality in Southern Brazil in 2019: a cross-sectional study. Epidemiol Serv Saude. 2023;32(1):e2022437. https://doi.org/10.1590/S2237-96222023000100025
29. Cai YX, Wang YJ, Liu J. Association between anxiety-depression status and psychological resilience in patients with Parkinson’s disease: A risk factor analysis. World J Psychiatry. 2025;15(8):108704. https://doi.org/10.5498/wjp.v15.i8.108704
30. Alis C, Demirelli DS, Ay E, Genc G. Depression and anxiety in Parkinson’s disease: prevalence and associated risk factors. Med Bull Sisli Etfal Hosp. 2025;59(2):200-5. https://doi.org/10.14744/SEMB.2025.90767
31. Tenison E, Henderson EJ. Multimorbidity and frailty: tackling complexity in Parkinson’s disease. J Parkinsons Dis. 2020;10(s1):S85-S91. https://doi.org/10.3233/JPD-202105
32. Burchill E, Watson CJ, Fanshawe JB, Badenoch JB, Rengasamy E, Ghanem DA, et al. The impact of psychiatric comorbidity on Parkinson’s disease outcomes: a systematic review and meta-analysis. Lancet Reg Health Eur. 2024;39:100870. https://doi.org/10.1016/j.lanepe.2024.100870
